Genentech/Biogen Idec Second Generation Anti-CD20 Marriage May Be On The Rocks
This article was originally published in The Pink Sheet Daily
Executive Summary
Dispute over rights to second generation anti-CD20 molecules could have a negative impact on development timelines, Genentech says.
You may also be interested in...
Biogen Idec Accelerates Development Of Rheumatoid Arthritis Candidate On Phase IIa Data
Company has initiated trials of the lymphotoxin beta fusion protein in two key RA patient populations.
Biogen Idec Accelerates Development Of Rheumatoid Arthritis Candidate On Phase IIa Data
Company has initiated trials of the lymphotoxin beta fusion protein in two key RA patient populations.
Genentech Alerts Of Tracheoesophageal Fistula Risk In Avastin Trial
Company is updating FDA about emerging risk of tracheoesophageal fistula in small cell lung cancer patients treated with Avastin.